Other languages Khiron Life Sciences Corp.

Equities

KHRN.H

CA49374L3065

Delayed Toronto S.E. Other stock markets 08:24:46 05/05/2023 pm IST			5-day change	1st Jan Change
0.04 ^CAD	-.--%		-.--%	-.--%

2023	Colombia's cannabis industry in crisis over regulatory, political hurdles	RE
2023	2518542 Alberta Ltd completed the acquisition of Khiron Europe Gmbh, Zerenia Clinics Limited, Khiron Life Sciences Spain SL, Khiron Life Sciences Uk and Pharmadrug Production GmbH from Khiron Life Sciences Corp..	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Con inversores agotados, la industria de cannabis en Colombia se marchita sin acceso a mercado y zonas grises	21/12
Colombia's cannabis industry in crisis over regulatory, political hurdles	21/12
2518542 Alberta Ltd completed the acquisition of Khiron Europe Gmbh, Zerenia Clinics Limited, Khiron Life Sciences Spain SL, Khiron Life Sciences Uk and Pharmadrug Production GmbH from Khiron Life Sciences Corp..	17/11
Khiron Life Sciences Corp. Enters into Partnership with an Accredited 3rd Party Contract Manufacturing Organization	21/23/21
Khiron Life Sciences Secures Additional Loan with Investment-Grade Bank	17/23/17
Khiron Edging Up as Notes NHS Reimburses Cost of Cannabis Treatment to First Zerenia Clinics UK Patient	16/23/16
Khiron Life Sciences Corp. Announces Full Reimbursement by the NHS of Costs Associated to Cannabis-Based Medication and Clinic Fees for A Patient Enrolled in Zerenia Clinics UK	16/23/16
Khiron Wins First Medical Cannabis Contract with Colombia's Largest Public Insurance Company	09/23/09
Khiron Up 41% As Notes Government of Colombia Declares Mandatory Insurance Coverage for Medical Cannabis Products	05/23/05
Khiron Life Sciences Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	29/22/29
Khiron Life Sciences Corp. Begins Sales in Switzerland and Expands Its Medical Cannabis Portfolio in Germany and the United Kingdom	16/22/16
Khiron Launches New Cannabis Products in Europe Including Stellar Genetics from California	01/22/01
Khiron Life Sciences Second-Quarter Loss Narrows on Higher Sales	29/22/29
Khiron Life Sciences Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	27/22/27
Khiron Life Sciences Corp. Announces the Opening of Zerenia™ Clinic in Brazil, Rio De Janeiro	09/22/09
Khiron Life Sciences Corp. (TSXV:KHRN completed the acquisition of Pharmadrug Production GmbH from Pharmadrug Inc..	02/22/02
Khiron Life Sciences Corp. Continues Global Expansion into Spain	06/22/06
Khiron Life Sciences Corp. Announces Resignation of Deborah Rosati from the Board of Directors	24/22/24
Khiron Life Sciences Completes Overnight Brokered Offering; Down 3.7%	10/22/10
Khiron Life Sciences to Buy EU-GMP-Certified German Pharmaceuticals Manufacturer and Wholesaler, Reports Q1 Results	31/22/31

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Khiron Life Sciences Corp.

Equities

KHRN.H

CA49374L3065

Other languages

Filters